Leveraging patients' longitudinal data to improve the Hospital One-year Mortality Risk

利用患者的纵向数据来改善医院一年死亡风险

阅读:2

Abstract

PURPOSE: Predicting medium-term survival after admission is necessary for identifying end-of-life patients who may benefit from goals of care (GOC) discussions. Considering that several patients have multiple hospital admissions, this study leverages patients' longitudinal data and information collected routinely at admission to predict the Hospital One-year Mortality Risk. METHODS: We propose the Ensemble Longitudinal Network (ELN) to predict one-year mortality using patients' longitudinal records. The model was evaluated: (i) with only predictors reported upon admission (AdmDemo); and (ii) also with diagnoses available later during patients' stay (AdmDemoDx). Using records of 123,646 patients with 250,812 hospitalizations from 2011 to 2021, our dataset was split into a learning set (2011-2017) to compare models with and without longitudinal information using nested cross-validation, and a holdout set (2017-2021) to assess clinical utility towards GOC discussions. RESULTS: The ELN achieved a significant increase in predictive performance using longitudinal information (p-value < 0.05) for both the AdmDemo and AdmDemoDx predictors. For randomly selected hospitalizations in the holdout set, the ELN showed: (i) AUROCs of 0.83 (AdmDemo) and 0.87 (AdmDemoDx); and (ii) superior decision-making properties, notably with an increase in precision from 0.25 for the standard process to 0.28 (AdmDemo) and 0.36 (AdmDemoDx). Feature importance analysis confirmed that the utility of the longitudinal information increases with the number of patient hospitalizations. CONCLUSION: Integrating patients' longitudinal data provides better insights into the severity of illness and the overall patient condition, in particular when limited information is available during their stay.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。